India to Germany: Amlodipine Export Trade Route
India has recorded 1,623 verified shipments of Amlodipine exported to Germany, representing a combined trade value of $10.8B USD. This corridor is served by 10 active Indian exporters, with an average shipment value of $6.7M USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 100% of total export value with 1,217 shipments worth $10.8B USD. On the buying side, B LOGISTIK GMBH is the largest importer in Germany with $10.8B USD in purchases. The top 3 suppliers — CIPLA LIMITED, IPCA LABORATORIES LIMITED, MACLEODS PHARMACEUTICALS LTD — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Germany Amlodipine corridor is one of India's established pharmaceutical export routes, with 1,623 shipments documented worth a combined $10.8B USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's amlodipine manufacturing sector.
Across 10 active suppliers, the average shipment value stands at $6.7M USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with amlodipine's non-urgent bulk-order profile.
Shipment activity peaks during January-March, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 9.4%, placing it at rank #7 among India's top amlodipine export destinations globally.
On the import side, key buyers of Indian amlodipine in Germany include B LOGISTIK GMBH, NA, NEXTPHARMA LOGISTICS GMBH and 15 others. B LOGISTIK GMBH is the single largest importer with 729 shipments valued at $10.8B USD.
